Author:
Kushwaha Sneha, ,K. Paliwal Sarvesh,Niranjan Divya
Abstract
2D QSAR has been performed on a series of pyridine carbonitrile and trifluoromethyl phenyl derivatives. 53 compounds were divided into training and test sets out of which 37 compounds generated a final QSAR model. The most significant model with n = 37, r = 0.916, r2 = 0.762, r2 cv = 0.759, s value = 0.388, f value = 41.76 was developed using MLR analysis. For PLS, the fraction of variance explained = 0.806 was observed. A comparable PLS model with r2 = 0.806 and Neural model with r2 = 0.853 indicated good internal predictability of the model. External test set validation provided r2 values of 0.744 and 0.768 for MLR and PLS analysis, respectively. Dipole moment Z Component, Log P, Shape flexibility index, and Vamp LUMO descriptors proved to be significant for inhibition of Cathepsin S. These findings will be effective in designing more potent and effective Cathepsin S inhibitors
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference76 articles.
1. 1. Bromme D. and Wilson, S.: Extracellular matrix degradation, Springer Link, Canada 2011, Vol. 2, pp. 23-51.
2. 2. Reiser J., Adair B. and Reinheckel T.: Specialized roles for cysteine cathepsins in health and disease, J. Clin. Invest., 2010, 120, 3421-3431.
3. 3. Guha S. and Padh H.: Cathepsins: Fundamental Effectors of Endolysosomal Proteolysis, Indian J. Biochem. Biophys., 2008, 45, 75-90.
4. 4. Mohamed M. M. and Sloane B. F.: Cysteine cathepsins: multifunctional enzymes in cancer, Nat. Rev. Cancer, 2006, 6, 764-775.
5. 5. Li Y. Y., Fang J. and Ao G. Z.: Cathepsin B and L inhibitors: a patent review, Expert Opin. Ther. Pat., 2016, 27, 643-656.